Table summarizing calculations of phase duration and transition probabilities for selected vaccine target disease areas.

a+ Projects do not transition from clinical trial phase III to regulatory submission phase;b++ Projects do not transition from clinical trials phase II to clinical trial Phase III;cStandard deviation/year;d95% Confidence Interval for the mean duration/year;eMerger and acquisition, deals in US$ Million since 2004.